Background: After one year since emerging from Wuhan, China, the Coronavirus disease 2019 (COVID-19) pandemic is still raging worldwide. Still, there is a dearth of original research exploring the attributes of COVID-19 patients from lower-and middle-income countries, such as Bangladesh. Based on a case series from a tertiary healthcare center, this observational study has explored the epidemiological and clinical profile of COVID-19 patients in Dhaka, Bangladesh. A total of 422 COVID-19 confirmed patients (via Reverse transcription-polymerase chain reaction test) were enrolled in this study. We have compiled patients' medical records and reported their demographic, socioeconomic, and clinical features, treatment history, health outcome, and post-discharge complications descriptively.Result: Patients were predominantly male (64%), between 35 to 49 years (28%), with at least one comorbidity (52%), and had COVID-19 symptoms for one week before hospitalization (66%). A significantly higher proportion (P<0.05) of male patients had diabetes, hypertension, and ischemic heart disease, while females had a significantly higher proportion (P<0.05) of asthma. The most common symptoms were fever (80%), cough (60%), dyspnea (41%), and sore throat (21%). Most patients received antibiotics (77%) and anticoagulant therapy (56%) and stayed in the hospital for an average of 12 days. Over 90% of patients were successfully weaned, while 3% died from COVID-19, and 41% reported complications after discharge.Conclusion: The diversity of clinical and epidemiological characteristics and health outcomes of COVID-19 patients across age groups and gender is noteworthy. Our result will inform the clinicians and epidemiologists of Bangladesh of their COVID-19 mitigation effort.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.